-
Symbol
-
KROS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
13,360 shares
-
Security Ownership %
-
0.04%
Shares, Excluding Options vs Price
ExodusPoint Capital Management, LP ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)
17 Feb 2026 - ExodusPoint Capital Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,360 shares of Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS).
This represents 0.04% ownership of the company.
In their previous filing dated 18 Nov 2025, ExodusPoint Capital Management, LP had reported owning 1,907,899 shares, indicating a decrease of +99%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.